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Abstract 
There is a growing trend of ‘replacing’ long-chain omega-3 polyunsaturated fatty acid (n-3 LC PUFA) 
rich oils with C18 shorter-chain omega-3 polyunsaturated fatty acid rich oils in Atlantic salmon 
aquafeed formulations. n-3 LC PUFA, including 20:5n-3 and 22:6n-3, play contrasting physiological 
roles and are metabolised differently in comparison to C18 PUFA. Accordingly, the present study 
recorded the effect of replacing n-3 LC PUFA rich dietary fish oil with C18 n-3 PUFA rich camelina oil at 
two inclusion levels in commercial-like diets fed to market-sized Atlantic salmon. This assessment was 
achieved by an analysis of industry relevant production parameters including growth performance, 
fatty acid composition and metabolism, nutrient digestibility and consumer preference (taste and 
sensorial analysis of fillet). The trial was conducted over the final 150 days of an on-farm grow-out 
period in seawater. The dietary replacement of n-3 LC PUFA with C18 n-3 PUFA resulted in a significant 
decrease in fillet n-3 LC PUFA and a poorer growth performance. However, in the absence of fish oil, 
the inclusion of camelina oil at high levels (40 %) contributed to an improved n-6/n-3 ratio and partially 
ameliorated low dietary n-3 LC PUFA by providing added substrate for endogenous n-3 LC PUFA 
synthesis in comparison to a 20% camelina oil inclusion. Furthermore, taste quality was largely 
unaffected by the dietary addition of camelina oil. Finally, this study provides evidence to suggest that 
a more complete reporting of the relative contribution of shorter-chain C18 n-3 PUFA and n-3 LC PUFA 
in fish and seafood products would benefit consumers from a nutritional quality standpoint. 
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1.0 Introduction 
The global population is increasingly reliant upon aquaculture to supply edible omega-3 long-chain 
polyunsaturated fatty acids (n-3 LC PUFA), despite a series of step-wise reductions in their dietary 
provision in commercial aquafeed formulations (Sprague et al. 2016; Subasinghe et al. 2009; Tocher 
2015). The stable supply of n-3 LC PUFA rich oils, primarily fish oil, can no longer be guaranteed due 
to stagnant production and increased competition originating outside of aquaculture, including 
nutraceutical and agricultural industries (Subasinghe et al. 2009; Tocher 2015; Turchini et al. 2010). 
Concomitant with the volatility of fish oil supply, the use of terrestrial oilseed crops rich in C18, shorter-
chain, n-3 PUFA as a dietary lipid source in aquafeed has increased (Bell et al. 2001; Bell et al. 2004; 
Turchini et al. 2010). n-3 LC PUFA, including 20:5n-3 and 22:6n-3, play contrasting physiological roles 
and are metabolised differently in fish and humans in comparison to C18 PUFA (Fard et al. 2018; 
Turchini et al. 2011b). Therefore, the growing trend of ‘replacing’ n-3 LC PUFA with shorter-chain n-3 
PUFA increases the pertinence of investigating the resultant metabolic and product quality impacts 
on cultured fish species. 
The Atlantic salmon (Salmo salar) aquaculture industry is a heavy consumer of marine derived n-3 LC 
PUFA and has addressed unstable fish oil supply via the incorporation of various terrestrial oil sources 
into aquafeed formulations (Turchini et al. 2009). Camelina (Camelina sativa) oil is one such oil which 
has been afforded recent attention, and similar to linseed/flaxseed oil, and to a lesser extent to canola 
oil, is characterised by high levels of 18:3n-3 (Hixson et al. 2014a; Hixson et al. 2014b). 18:3n-3 is 
considered an essential fatty acid as it cannot be synthesised by animals or humans and is the 
precursor of longer-chain, more unsaturated fatty acids 20:5n-3 and 22:6n-3 (n-3 LC-PUFA), which 
reportedly possesses numerous health benefits, in-part due to anti-inflammatory and cardio-
protective properties (Baum et al. 2012; Nestel et al. 2015; Turchini et al. 2011b). Whilst the main 
dietary source of n-3 LC PUFA is fish and seafood, 18:3n-3 can be consumed from a wide variety of 
terrestrial dietary sources (Abedi & Sahari 2014; Garg et al. 2006; Simopoulos 2000). It is known that 
in the absence of added n-3 LC PUFA, several fish species, including Atlantic salmon, have the capacity 
to endogenously produce 20:5n-3 and 22:6n-3 when provided 18:3n-3 as a substrate for in vivo 
bioconversion (Nakamura & Nara 2004; Tocher 2003). However, the extent of endogenous n-3 LC-
PUFA production is limited and dependent on: i) both substrate (18:3n-3) and end-product (22:6n-3) 
availability; ii) on the physiological requirement for 22:6n-3, which itself is influenced by a number of 
factors including developmental stage and water temperature (Tocher et al. 2003; Torstensen et al. 
2004; Turchini & Francis 2009; Turchini et al. 2011b); and iii) on other external factors, such as, 
amongst others, dietary co-enzyme and co-factor availability (Giri et al. 2016; Lewis et al. 2013; 
Senadheera et al. 2012b, a) and the presence of promoters or inhibitors (Pickova et al. 2010). 
Nevertheless, the endogenous production of 22:6n-3 from 18:3n-3 is not considered sufficient to 
substantially enrich the fillet with 22:6n-3 to the same extent as dietary fish oil (Cleveland et al. 2012; 
Francis et al. 2007; Tocher et al. 2003; Turchini & Francis 2009). 
Owing to the extensively reported health benefits of n-3 LC PUFA (Garg et al. 2006; Kris-Etherton et 
al. 2002; Ruxton et al. 2004; Valfré et al. 2003), health agencies have long iterated the importance of 
fish consumption (Meyer 2016; NHFA 2008). However, an enhanced holistic approach regarding the 
‘healthy’ consumption of fatty acids advocates the consumption of a diet which also minimises the n-
6 to n-3 fatty acid ratio (Calder 2010; Nestel et al. 2015; Simopoulos 2008; Turchini et al. 2011b). The 
balance of these fatty acids has become a relative measure of the health promoting benefit of oil 
sources due to reported anti-inflammatory properties and resultant risk reduction of cardiovascular 
disease achieved by diets with a reduced n-6/n-3 ratio (Abedi & Sahari 2014; Harris et al. 2009; 
Simopoulos 2000, 2002, 2008; Turchini et al. 2011b). Despite the aforementioned functional 
differences between 18:3n-3 and 22:6n-3, the reported n-6/n-3 ratio in fish often does not distinguish 
between long and short-chain n-3 fatty acids and as a result has the potential to mislead consumers, 
who fail to make this technical distinction (Turchini et al. 2011b). This re-iterates the importance of 
distinguishing the effects of dietary lipid sources of C18, shorter-, and C20-22, long- chain fatty acids in 
aquafeed on the overall health characteristics of Atlantic salmon. 
Notably, the adoption of dietary formulations in aquaculture clearly depends on more than the 
‘healthiness’ of the fillet product. Indeed, overall fish performance, including growth remains a 
primary consideration of producers (Lysfjord et al. 2004; Rosenlund et al. 2016; Thorarensen et al. 
2015). To date, few long-term growth trials have been conducted with salmon in seawater fed diets 
containing low n-3 LC PUFA concentrations, although admittedly, its dietary addition appears essential 
for optimal growth (Bell et al. 2010; Rosenlund et al. 2016). The present study compared three 
commercial-like diets containing either added n-3 LC PUFA, from fish oil, or added shorter-chain n-3 
PUFA (at two levels), from camelina oil to assess growth performance, fillet fatty acid composition, 
nutrient and fatty acid digestibility, in vivo fatty acid metabolism, and sensorial characteristics in 
market-sized Atlantic salmon. 
 
2.0 Materials and Methods 
2.1 Location, animals, experimental design and sampling. 
The present experiment was conducted on a commercial farm, from May 24 to October 20, 2015 (150 
days) in Hideaway bay, Dover, Tasmania (Huon Tasmania, Hideaway bay site; 43°15′ 52.2″S 
147°04′37.7″E). Immediately preceding the allocation of fish into trial pens an initial sample of 6 fish 
were randomly taken from the trial cohort, euthanized in excess anaesthetic (AQUI-S, 0.5 ml L-1) and 
stored at −20 °C until subsequent analysis. A total of 2430 Atlantic salmon (average initial weight 
~2200g) were assigned to one of nine floating sea pens (5m x 5m x 5m, 270 fish per pen) (n = 3, N = 
9). Feeding of the three experimental diets to trial pens was achieved by using a Sterner feeder fitted 
with a 40 L hopper and spinning feed spreading mechanism that dispersed feed over ~80% of the cage 
surface. Fish were fed twice per day to satiation by an automated AQ1 feed system, with the first 
feeding programmed for 15 minutes before sunrise and the second feeding 15 minutes after sunset. 
A 0.5 m diameter, 0.5 m deep cone was positioned at a depth of 4 m to channel uneaten feed past an 
infrared sensor which detected uneaten pellets and automatically turned the feeder off. All feeding 
sessions were overseen by an observer to ensure the operation of all automated systems were correct 
and consistent. Feed consumption and mortalities were monitored throughout the trial and physio-
chemical parameters were recorded, including water temperature (mean ± SD: 11.21 ± 0.86 oC) and 
dissolved oxygen (mean ± SD: 7.85 ± 0.43 mg L-1). During the last week of feeding, 10 fish were 
randomly selected for faecal collection by hand stripping and samples were used for subsequent 
nutrient digestibility assessment. At the completion of the feeding trial, all fish were anaesthetised 
and weighed, and 21 fish from each treatment (seven fish per pen/replicate unit) were randomly 
selected and separated. These fish were allocated into 3 groups: the first group (nine fish) were used 
for the chemical analysis of whole body samples, the second group (six fish) were used for biometrical 
measurements and for the chemical analysis of fillet samples and the third group (six fish) were used 
for sensory analysis by means of a panel taste test. Sampled fish were immediately placed in an ice 
slurry, where fish used for chemical analysis were then frozen to −20 °C and stored until subsequent 
analysis, while fish allocated to panel taste testing were immediately processed by Huon Aquaculture 
Company, Tasmania, as described below.  
 
2.2 Experimental Diets 
The experimental diets were manufactured by a commercial feed producer using a closed formula 
Atlantic salmon aquafeed formulations (Ridley Aquafeed, Australia). A single batch of 9mm pellets 
with an identical basal formulation was made, then divided into three separate sub-batches post 
extrusion and vacuum coated with different oils. The three diets were isoproteic, isolipidic and 
isoenergetic and differed only in the added oil source. All diet manufacturing followed normal 
commercial pellet production procedures at a commercial mill (Ridley Aquafeed, Narangba, QLD, 
Australia). 
Three lipid sources, tallow, fish oil and camelina oil, were used to obtain the three experimental diets. 
The FO20 diet was formulated with 20% fish oil and 80% tallow as the added dietary lipid. FO20 was 
therefore the diet providing dietary omega-3 fatty acids in the form of n-3 LC PUFA. The CAM20 diet 
also contained 80% tallow, however, fish oil was substituted by camelina oil resulting in dietary lipid 
composed of 20% camelina oil and 80% tallow. The third treatment diet was made up of 60% tallow 
and 40% camelina oil as the added dietary lipid (CAM40). The CAM20 and CAM40 were therefore the 
two diets providing dietary omega-3 fatty acids in the form of the shorter, C18 n-3 PUFA, at two 
different levels. 
 
2.3 Growth performance, chemical analysis and fatty acid analysis  
Standard formulae were used to assess growth, feed utilisation and biometrical data, as previously 
described (Emery et al. 2016). The chemical composition of the experimental diets, faeces and fish 
samples were determined via proximate composition analysis according to standard methods as 
previously described (Palmeri et al. 2007). Briefly, moisture was determined by drying samples in an 
oven at 80 °C to a constant weight. Ash was determined by incinerating samples in a muffle furnace 
(S.E.M. SA Pty. Ltd., Australia) at 550 °C for 18 h. Protein (Kjeldahl nitrogen: N × 6.25) content was 
determined using an automated Kjeltech 2300 (Foss Tecator, Geneva, Switzerland). Lipid was 
determined by dichloromethane: methanol extraction (2/1) according to Folch et al. (1957), where 
dichloromethane was used to replace chloroform for safety considerations. Following lipid extraction, 
fatty acids were esterified into methyl esters using an acid-catalysed methylation method and then 
analysed by gas chromatography. Briefly, a known aliquot of C23:0 was added to each sample as an 
internal standard (Sigma-Aldrich, Inc., St. Louis, MO, USA). Fatty acid methyl esters were isolated and 
identified using an Agilent Technologies GC 7890A (Agilent Technologies, Santa Clara, California, USA) 
equipped with a BPX70 capillary column (120 m, 0.25 mm internal diameter, 0.25-μm film thickness; 
SGE Analytical Science, Ringwood, Victoria, Australia), a flame ionisation detector (FID), an Agilent 
Technologies 7693 autosampler injector, and a split injection system (split ratio 50/1). Fatty acids were 
identified relative to known external standards, and resulting peaks were corrected by the theoretical 
relative FID response factors and for methyl transformation, and then quantified relative to the 
internal standard.  
 
2.4. Nutrient digestibility and fatty acid metabolism calculations  
Evaluation of digestibility was determined following methods in Atkinson (1984), the only difference 
being ash was used instead of acid insoluble ash. The calculation of apparent in vivo fatty acid 
metabolism was performed using the whole-body fatty acid balance method, as initially proposed and 
described by Turchini et al., (2007) with further development (Turchini et al. 2008; Turchini & Francis 
2009). 
 
2.5. Consumer acceptance testing 
Six fish from each treatment (two per cage) were further subdivided in three sub-groups and were 
subject to standard commercial processing procedures, resulting in three different preparations: hot 
smoked, cold smoked and fresh fillet. 
Methods for consumer acceptance testing were based on methods previously described in Emery et 
al., (2016). In the present study, a total of 35 regular salmon consumers (20 female, 15 male; age 37 ± 
5) were recruited from locations adjacent to the Deakin University, Melbourne campus, Australia. All 
participants completed a validated version of the Food Frequency Questionnaire (FFQ) developed by 
Cancer Council Victoria (Hodge et al. 2000), which included a specific salmon questionnaire to 
determine that they consumed salmon or salmon products at least once every two weeks. This study 
was conducted according to the institutional review board regulations of Deakin University (DUREC 
2013-156). The experimental protocol was also registered under the Australian New Zealand Clinical 
Trials Registry (ACTRN12613000701729). All participants gave written informed consent and were 
paid to participate. Participants attended a single lab session which included training for using the 
hedonic Labelled Magnitude Scale (hedonic LMS) (Lim 2011) (Figure S1) and completion of a like / 
dislike questionnaire prior to rating their liking of different salmon products using the hedonic LMS). 
Procedures were conducted in partitioned sensory booths in the Centre for Advanced Sensory Science 
using Compusense Cloud Software as part of the Compusense Academic Consortium (Compusense 
Inc., Ontario, Canada). The hot smoked and cold smoked salmon were prepared as previously noted 
and served to assessors after removal from packaging without any further treatment, the raw salmon 
was thawed at room temperature each morning prior to assessment. Each participant was first given 
approximately 15 g of each sample to rate their liking using the hedonic LMS. After a one minute 
break, participants were given the same samples again, but were then asked to rate the intensity of 
fishy, salty and oily attributes using a Just About Right scale. In this case a positive value indicated a 
sample was too high in the attribute and a negative score indicated a sample was lacking the attribute. 
Thereby, for the influential attributes, a score close to zero indicated the sample was ‘just about right’. 
These attributes were chosen after bench-top testing determined they may influence liking. Finally, 
participants were given the opportunity to comment on each sample or whether there were additional 
factors that had influenced their liking. 
 
2.6. Statistical analysis 
All data were reported as mean ± standard error; (n = 3, N = 9). After confirmation of normality and 
homogeneity of variance, data was subjected to one-way ANOVA, where significant differences were 
detected, a Tukey’s post-hoc test for homogenous subsets was performed using IBM SPSS Statistics 
v24.0 (SPSS Inc., Chicago, IL, USA). Significance was accepted at P < 0.05. 
 
3.0 Results 
3.1 Diets 
Proximate composition was similar between the three treatment diets, ~420 mg g-1 diet and ~350 mg 
g diet-1 for protein and lipid, respectively (Table 1). n-6 PUFA varied across treatments and was highest 
in CAM40, attributable to high levels of 18:2n-6. Likewise, n-3 PUFA concentrations varied between 
treatments and were highest in CAM40, owing to high levels of 18:3n-3, and lowest in FO20. n-3 LC 
PUFA was highest in FO20 owing to elevated concentrations of 20:5n-3 and 22:6n-3. n-6/n-3 ratios 
were similar in FO20 and CAM40 (0.9 and 1.0, respectively) and markedly higher in CAM20 (1.9). 
 
3.2. Growth, feed utilisation parameters and biometrical data 
All diets were readily accepted and mortality rates were low across treatments (<6%, over the entire 
duration of the trial, and unrelated to treatment). Fish doubled in size (2200g – 4500g), with an FCR 
ranging between 1.34 and 1.63 in FO20 and CAM20 treatments, respectively (Table 2). Both SGR and 
weight gain % were significantly higher in the FO20 treatment (P < 0.05) and fish were observably 
larger, however, final weights were not statistically different. There were no significant differences in 
biometry measures between the treatments.  
 
3.3. Apparent digestibility 
High nutrient and fatty acid digestibility values (Apparent Digestibility Coefficient – ADC %) were 
observed across treatments, with only few statistically significant differences recorded (Table 3). 
Protein digestibility values ranged from 74.1 to 80.2 % in FO20 and CAM20, respectively and lipid 
digestibility values ranged from 78.5 to 84.8 % in FO20 and CAM40, respectively. Digestibility values 
recorded for 18:3n-3 ranged from 88.1 to 96.6 % in FO20 and CAM20, respectively and digestibility 
values for 22:6n-3 ranged from 87.8 and 93.6 % for FO20 and CAM20, respectively. 
 
3.4. Tissue proximate and fatty acid composition 
Proximate composition of fillet was similar between treatments and no significant differences were 
recorded (P > 0.05) (Table 4). Fillet fatty acid composition, in terms of g 100g-1 of fillet (Table 5), 
recorded numerous statistically significant differences, including higher SFA in FO20 (2814.6 mg 100g-
1 fillet). n-6 PUFA differed significantly between all treatments ranging from 743.0 to 1276.6 mg 100g-
1 of fillet in FO20 and CAM40, respectively. n-3 LC PUFA also varied between treatments ranging from 
458.5 to 718.3 mg 100g-1 fillet in CAM20 and FO20, respectively, owing largely to differences in 22:6n-
3 (P < 0.05). The n-6/n-3 ratio varied substantially between treatments, ranging from 0.9 to 1.6 in 
FO20 and CAM20, respectively. Trends were similar when expressed as µmol g-1 fillet and revealed 
significant differences in 18:3n-3 content which ranged from 3.8 to 14.0 µmol g-1 in FO20 and CAM40, 
respectively (P < 0.05) (Table 4). 
 
3.6. Apparent in vivo fatty acid metabolism 
Apparent in vivo fatty acid β-oxidation and apparent in vivo fatty acid bioconversion, as calculated by 
the whole-body fatty acid balance method, are presented in tables 6 and 7. Fatty acid β-oxidation 
(expressed as nmol of fatty acid β-oxidised per gram of fish per day; nmol g-1 day-1) revealed 18:1n-9 
was heavily β-oxidised in all treatments. High β-oxidation of 16:0 was recorded in FO20 and CAM20, 
however, almost no β-oxidation of SFA was recorded for CAM40. Significantly more EPA and DHA was 
β-oxidised in fish fed FO20 and was in line with dietary inclusion levels. β-oxidation of 18:3n-3 also 
followed dietary inclusion levels and was significantly higher in fish fed CAM40 and minimal in FO20. 
Apparent in vivo enzyme activity for fatty acid elongation, fatty acid desaturation and fatty acid chain 
shortening, (expressed as nmol of product per gram of fish per day; nmol g-1 day-1) varied considerably 
between treatments and numerous statistically significant differences were observed. In general, the 
highest enzymatic activity was observed in CAM40 including de novo fatty acid production of 12:0. 
Fatty acid elongation of 12:0, 14:0 and 16:0 were also high in CAM40 and were not recorded in the 
other treatments. n-3 PUFA bioconversion was highest in CAM40, including ∆-5 desaturation of 20:4n-
3 to biosynthesise 20:5n-3, and chain shortening of 24:6n-3 for 22:6n-3 production. 
 
3.6. Consumer preferences 
No significant difference in liking score between dietary treatments for the three preparation 
methods, (hot smoked, cold smoked and raw), was observed (Table 8). FO20 scored the highest liking 
score for the raw preparation method whilst CAM20 and CAM40 scored highest in liking scores for the 
hot smoked and cold smoked preparation methods, respectively. Overall, ‘just right’ scores were 
similar between treatments for the influential attributes (fishiness, saltiness and oiliness) and trends 
observed appeared to be related to preparation method and not treatment. One significant difference 
was recorded; CAM20 scored significantly higher than FO20 for the saltiness attribute for the cold 
smoked preparation method (11.04 and 6.31 on the ‘just right scale’, respectively) (P < 0.05). 
 
4.0 Discussion 
The objective of the present study was to quantify the effects of replacing n-3 LC PUFA with shorter-
chain C18 n-3 PUFA in diets for Atlantic salmon in response to the growing trend of substituting fish 
oil with terrestrial alternatives containing C18 n-3 PUFA in aquafeed formulations. It is known that, 
due to functional differences, n-3 LC PUFA and C18 n-3 PUFA are not metabolised equally and this 
could potentially be affecting both fish performance and product quality in this species (Bell et al. 
2004; Betancor et al. 2017; Hixson et al. 2014a; Turchini et al. 2011b; Xue et al. 2015). Accordingly, 
industry relevant information including an analysis of growth performance, fillet nutritional quality, 
in vivo fatty acid metabolism and an evaluation of consumer taste preference were addressed in this 
experiment and are discussed herein. 
It is widely reported that the replacement of fish oil with vegetable and animal by-product oils in 
diets for salmonids has little effect on overall growth performance, even when included as 100 % of 
the dietary lipid source (Bell et al. 2010; Bransden et al. 2003; Hixson et al. 2014a; Karalazos et al. 
2007; Menoyo et al. 2005; Torstensen et al. 2000). Despite this, a minimum dietary requirement for 
20:5n-3 and 22:6n-3 for optimum growth in seawater for large Atlantic salmon has been suggested 
(>2.7 % of fatty acids) (Rosenlund et al. 2016). In the current trial the dietary treatments containing 
no added fish oil recorded ~20% lower total weight gain compared to the FO20 treatment. 
Therefore, this study supports a minimum dietary provision of fish oil in diets for market-sized 
Atlantic salmon reared in on-farm conditions in seawater to maintain optimum growth performance. 
Alternatively, considering no other detrimental effects were observed, if the cost saving resulting 
from the exclusion of fish oil from feed formulation could be greater than the reduced revenues 
originating from the retarded fish growth, specific production decisions could be implemented 
accordingly. This would require a deeper and specific bio-economical assessment, which was not an 
objective of the present study, but may be warranted in future investigations. 
In line with extensive research, fillet fatty acid composition reflected dietary inclusion levels (Bell et 
al. 2001; Bell et al. 2002; Bell et al. 2004; Emery et al. 2016; Francis & Turchini 2017; Friesen et al. 
2008; Glencross et al. 2014; Hixson et al. 2014b; Jobling & Bendiksen 2003; Karalazos et al. 2007; 
Robin et al. 2003; Rosenlund et al. 2001; Tocher et al. 2003; Torstensen et al. 2000; Turchini et al. 
2013). As expected, fillet levels of n-3 LC PUFA were significantly higher in FO20, compared to the no 
fish oil treatments, and confirm that in order for farmed Atlantic salmon to maintain their reputation 
as a good source of n-3 LC PUFA, the dietary inclusion of n-3 LC PUFA in aquafeed is required 
(Henriques et al. 2014; Sargent et al. 2003; Tur et al. 2012). Despite higher total 22:6n-3 
concentrations in the fillet of FO20 fish, the deposition efficiency was noticeably lower, as evidenced 
by the significantly higher β-oxidation of both 20:5n-3 and 22:6n-3. Contrastingly, the β-oxidation of 
20:5n-3 and 22:6n-3 was minimal in both CAM20 and CAM40 (both as total fatty acid β- oxidation 
and as % relative to net intake), supporting previous research which suggests an increased retention 
of n-3 LC PUFA when dietary provision is limited (Codabaccus et al. 2012; Francis et al. 2014; 
Pratoomyot et al. 2010; Turchini et al. 2011a). 
Despite similar dietary levels of n-3 LC PUFA, CAM40 recorded higher levels of n-3 LC PUFA in the 
fillet compared to CAM20. A possible explanation may relate to the capacity of numerous freshwater 
and anadromous fish, including Atlantic salmon, to endogenously produce n-3 LC PUFA via the 
desaturation and elongation of 18:3n-3 (Nakamura & Nara 2004; Tocher 2003). 18:3n-3 rich 
terrestrial oils are more readily available for the inclusion into aquafeed formulations compared to 
22:6n-3 rich fish oil (Turchini et al. 2010). Hence, previous research has focussed on the dietary 
manipulation of shorter vs long-chain n-3 PUFA ratios in an attempt to ‘augment’ the endogenous 
synthesis of n-3 LC PUFA in commercially important finfish species such as Atlantic salmon (Betancor 
et al. 2014; Francis et al. 2007; Olsen & Ringø 1992; Ruyter & Thomassen 1999; Tocher et al. 2002; 
Torstensen et al. 2004; Turchini & Francis 2009). Marine environments contain an abundance of 
dietary sources of 22:6n-3 and accordingly endogenous production of 22:6n-3 in marine fish is 
limited. In contrast, dietary sources of 22:6n-3 in freshwater environments are relatively scarce, 
where resultantly, the endogenous production of 22:6n-3 is believed to be an evolutionary 
adaptation by freshwater and anadromous fish to meet physiological requirements (Tocher 2003). 
However, research suggests that the activity of the ∆-6 desaturase enzyme in salmonids, which 
catalyses the first, and one of the last, steps of the n-3 bioconversion pathway, is modulated 
primarily by the provision of n-3 substrate and that the negative feedback modulation by dietary 
provision of LC PUFA may have a limited influence (Glencross et al. 2014; Hixson et al. 2017; 
Thanuthong et al. 2011; Thomassen et al. 2012; Turchini & Francis 2009). With respect to the 
present study, CAM40 contained threefold higher dietary concentrations of 18:3n-3 compared to 
CAM20, and although not significant, recorded a higher ∆-6 desaturation of 18:3n-3. Subsequently, 
CAM40 recorded a ∆-5 desaturation of 20:4n-3, an elongation of 20:5n-3 and ultimately an 
endogenous production of 22:6n-3, although final amounts were limited. CAM20 on the other hand 
recorded no production of n-3 LC PUFA beyond 20:4n-3. Therefore, in accordance with previous 
research, the higher dietary provision of 18:3n-3 in CAM40 explains the higher enzymatic activity in 
the n-3 PUFA bioconversion pathway, which may have contributed to higher fillet levels of n-3 LC 
PUFA (Thanuthong et al. 2011; Thomassen et al. 2012; Turchini & Francis 2009). As mentioned, 
higher levels of n-3 LC PUFA were recorded in the fillet tissue of CAM40 fish compared to fish fed the 
CAM20 diet, despite similar amounts provided in the diet and limited recorded endogenous 
production of 22:6n-3. The inability to detect large amounts of endogenous 22:6n-3 production in 
CAM40 fish using the whole-body fatty acid balance method may be a result of limitations when this 
method is applied to on-farm situations. These limitations may arise from a less efficient 
incorporation of dietary supplied fatty acids into the fish, owing to a typically higher FCR on-farm 
compared to laboratory-based trials. Concomitantly, inaccuracies associated with feed delivery and 
consumption measurements can result in a considerable over or under-estimation of feed inputs.  
Resultantly, dietary fatty acid availability is overestimated and, therefore, contributes to an 
underestimation of final whole-body fatty acid balance. Nevertheless, the apparent limited 
biosynthesis of 22:6n-3 in CAM40 likely indicates there are other factors responsible for the higher 
fillet 22:6n-3 in CAM40 fish. The most obvious explanation relates to the marginally higher dietary 
level of n-3 LC PUFA in CAM40 treatment diets as well as the increased retention of 22:6n-3, as 
evidenced by lower a β-oxidation of this fatty acid, both in terms of µmol g-1 day-1 and % of net 
intake. Withstanding the aforementioned limitations, this study suggests that if fish oil is replaced by 
camelina oil, a relatively high (~40%) dietary addition is favourable to enhance the n-3 LC PUFA 
content of the fillet. Furthermore, relative to a 20% inclusion of camelina oil, a reduction in the n-
6/n-3 ratio was achieved, leading to net gains in potential health benefits (Harris et al. 2009; 
Simopoulos 2008). However, due to the multiple explanatory factors presented herein, further 
investigation is required to better quantify the effects on endogenous production of n-3 LC PUFA in 
large Atlantic salmon fed diets containing very low n-3 LC PUFA and varied levels of 18:3n-3 as a 
substrate for in vivo bioconversion. 
As highlighted, dietary provision of 18:3n-3 influences the extent of n-3 PUFA bioconversion in 
salmonids, where more specifically, in vivo enzymatic activity appears proportional to 18:3n-3 
substrate availability (Glencross et al. 2014; Hixson et al. 2017; Thanuthong et al. 2011). However, 
despite a minimal dietary provision, >60 % of 18:3n-3 was either desaturated or elongated in the 
FO20 dietary treatment. Despite no dietary provision of 18:4n-3, endogenous synthesis of 20:4n-3 
was significantly higher in the FO20 treatment, however, no production of 20:5n-3 was recorded. It 
appears, in accordance with previous research, that the dietary provision of n-3 LC PUFA in the FO20 
diet elicited a partial negative feedback on ∆-5 desaturase enzyme activity, yet did not inhibit ∆-6 
desaturase enzyme activity (Glencross et al. 2014; Hixson et al. 2017; Thanuthong et al. 2011; 
Thomassen et al. 2012). However, considering the low dietary provision of 18:3n-3 there are likely 
other factors contributing to the high bioconversion rate. The high dietary 20:4n-6 in the FO20 diet 
relative to the other experimental diets has the potential to increase ∆-6 desaturation of 18:3n-3, as 
suggested by previous research in juvenile Atlantic salmon (Norambuena et al. 2015). Additionally, 
the ∆-6 desaturase enzyme has a higher affinity with n-3, as opposed to n-6 substrates, namely 
18:2n-6 (Vagner & Santigosa 2011). Thus, the relatively low dietary concentration of 18:2n-6 in FO20 
compared to the other treatment diets may have resulted in a preferential desaturation of 18:3n-3. 
 
Atlantic salmon contain a ‘healthy’ n-6/n-3 ratio, which in turn is a direct consequence of balanced 
aquafeed formulations (Bendiksen et al. 2011; Leaver et al. 2011; Strobel et al. 2012; Turchini et al. 
2010). The present study highlights the different utilisation of 18:3n-3 and 22:6n-3 in Atlantic 
salmon, in turn, affecting the nutritional value of the final product. The dietary n-6/n-3 ratios in FO20 
and CAM40 were similar (0.9 and 1.0, respectively), however, in FO20 this was comprised primarily 
of long-chain n-3 PUFA, whereas CAM40 consisted of mostly C18 n-3 PUFA. In accordance with 
previous research, 18:3n-3 was heavily β-oxidised and this was reflected in fillet n-6/n-3 ratios which 
recorded values of 0.9 and 1.4 for FO20 and CAM40, respectively (in terms of mg 100g-1 of fillet) (Bell 
et al. 2001; Bell et al. 2003a; Bell et al. 2003b; Sinclair et al. 2002). Therefore, dietary n-6/n-3 dietary 
ratios in CAM40 were not reflected in the fillet.  
From a human nutritional viewpoint, an unbalanced dietary n-6/n-3 ratio continues to be used as a 
measure of the overall ‘health’ of the final product, owing the a purported decrease in occurrence of 
inflammatory conditions such as cardiovascular disease (Baum et al. 2012; Calder 2010; Harris et al. 
2009; Simopoulos 2008; Valfré et al. 2003). However, the relative contribution of 18:3n-3 and 22:6n-
3 to total n-3 PUFA is often omitted (Turchini et al. 2011b). To date, there is scant information 
available specifically linking 18:3n-3 to health benefits in humans, conversely, the health benefits of 
22:6n-3 have been extensively reported, leading to a potential misinterpretation of the actual health 
benefit of the product (Fard et al. 2018; Turchini et al. 2011b). Furthermore, dependant on 
marketing strategy and resultant labelling practice, nutritional information can often be confined to 
total ‘omega-3’ or ‘omega-3 polyunsaturated fatty acids’ (Turchini et al. 2011b). In the present study, 
fish fed the CAM40 diet contained higher (albeit not statistically) n-3 PUFA in the fillet compared to 
FO20, largely due to high 18:3n-3, however, fish fed the FO20 diet had significantly higher n-3 LC 
PUFA. The aforementioned results exemplify the need to consider the relative contribution of 18:3n-
3 and 22:6n-3 when assessing the nutritive value of both aquafeed and the final fish product. 
Accordingly, it is suggested that products advertising levels of ‘omega-3’ contain a more complete 
set of nutritional information, specifically, elucidating the relative contribution of individual fatty 
acids, especially, shorter-chain C18 n-3 PUFA and long-chain n-3 PUFA. 
In addition to the nutritional value, taste and sensorial quality is also a major driver of fish 
consumption (Christenson et al. 2017). The present study indicated that consumer preference; like 
(+) or dislike (-) and influential attribute scores from raw, cold and hot smoked fillets was largely 
independent of the dietary treatment. The possible exception was CAM20, which scored a higher 
positive result for saltiness compared to FO20 when prepared raw (i.e. was considered too salty). 
These results are largely confirmatory with Hixson et. al., (2017), who found that consumers were 
unable to distinguish between fish fed a diet containing camelina oil and fish fed a fish oil control 
diet, providing confidence that the dietary inclusion of camelina oil, in the absence of fish oil has no 
measurable effect on major taste attributes in market-sized Atlantic salmon. 
 
In summary, the replacement of n-3 LC PUFA with C18 n-3 PUFA in diets for Atlantic salmon resulted 
in a significant decrease in fillet n-3 LC PUFA and a reduction in growth performance. However, in 
the absence of fish oil, the inclusion of camelina oil at high levels (40 %) contributed to an improved 
n-6/n-3 ratio and may partially ameliorate low dietary n-3 LC PUFA by providing added substrate for 
endogenous n-3 LC PUFA synthesis in comparison to 20% camelina oil inclusion. Furthermore, taste 
quality is largely unaffected by the dietary addition of camelina oil. This study provides evidence to 
suggest that a more complete reporting of the relative contribution of shorter-chain C18 n-3 PUFA 
and n-3 LC PUFA in fish and seafood products would benefit consumers. 
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Figure 1. Hedonic LMS liking scale used in Compusense for the sensory analysis of liking scores for 
Atlantic salmon prepared three different ways: hot smoked, cold smoked and raw. 
  
Table 1       
Proximate and fatty acid (mg g-1 diet) composition of experimental diets 
used in the Atlantic salmon growth trial for 150 days. 
  Dietsa     
  FO20 CAM20 CAM40 
Proximate composition    
Moisture  44.3 46.0 34.9 
Protein 402.6 434.2 438.8 
Lipid 358.2 324.2 354.4 
NFE 125.0 124.4 98.8 
Ash 69.9 71.2 73.2 
Energy (KJ g-1) 25.8 25.2 26.1 
Fatty acids composition 
Total FAb 250.9 246.0 253.0 
SFAc 104.1 105.9 84.1 
14:0 7.9 5.8 4.9 
16:0 60.8 57.4 48.3 
18:0 31.2 38.4 26.8 
Other SFAd 4.2 4.3 4.1 
MUFAe 115.4 104.8 110.8 
16:1n-7 10.6 7.3 6.8 
18:1n-9 86.0 86.2 82.1 
18:1n-7 5.2 4.2 4.0 
20:1n-9 4.6 3.5 11.1 
Other MUFAf 9.0 3.7 6.8 
Total trans FAg 5.2 3.9 4.1 
PUFAh 25.9 30.9 53.8 
18:2n-6 9.4 17.7 23.7 
18:3n-6 0.1 0.1 0.2 
20:2n-6 0.5 0.7 1.4 
20:3n-6 0.6 0.8 0.6 
20:4n-6 0.7 0.5 0.3 
Other n-6 PUFAi 0.9 0.5 0.6 
n-6 PUFAj 12.2 20.2 26.8 
n-6 LC PUFAn 2.7 2.4 3.1 
18:3n-3 2.0 7.5 23.4 
20:5n-3 3.9 1.0 1.0 
22:5n-3 1.0 0.3 0.3 
22:6n-3 5.8 1.6 1.6 
Other n-3 PUFAl 0.6 0.3 0.7 
n-3 PUFAk 13.3 10.7 27.0 
n-3 LC PUFAo 11.3 3.2 3.6 
LC PUFAm 14.0 5.6 6.6 
n-6/n-3 ratiop 0.9 1.9 1.0 
a Diets: FO20 = tallow and fish oil diet, added oil 20% fish oil, 80% tallow; 
CAM20 = tallow and camelina oil diet, added oil 80% tallow, 20% camelina 
oil; CAM40 = tallow and camelina oil diet, added 60% tallow, 40% camelina 
oil. 
b Total FA = total fatty acids mg g-1 of diet. 
c SFA = saturated fatty acids. 
d Other SFA = sum of 12:0, 15:0, 17:0, 20:0, 22:0 and 24:0. 
e MUFA = monounsaturated fatty acids. 
f Other MUFA = sum of 14:1n-5, 15:1n-5, 17:1n-7, 20:1n-13, 20:1n-11, 22:1n-
11, 22:1n-9 and 24:1n-9. 
g Total trans FA = sum of 18:1n-9t, 18:1n-7t and 18:2n-6t. 
h PUFA = polyunsaturated fatty acids. 
i Other n-6 PUFA = sum of 20:2n-6, 22:2n-6, 22:4n-6 and 22:5n-6. 
j n-6 PUFA = omega-6 polyunsaturated fatty acids. 
k n-3 PUFA = omega-3 polyunsaturated fatty acids. 
l Other n-3 PUFA = sum of 18:4n-3, 20:3n-3, 20:4n-3, 24:5n-3 and 24:6n-3. 
m LC-PUFA = long chain (>20C) polyunsaturated fatty acids. 
n n-6 LC PUFA = omega-6 long chain polyunsaturated fatty acids. 
o n-3 LC PUFA = omega-3 long chain polyunsaturated fatty acids. 
p n-6/n-3 ratio = ratio between n-6 PUFA and n-3 PUFA. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
  
Table 2 
Growth, feed efficiency and biometry of Atlantic salmon fed the three experimental diets for 
150 days. 
  Dietsa     
  FO20 CAM20 CAM40 
Initial wt (g) 2164 ± 37 2272 ± 34 2285 ± 2 
Final wt (g) 4835 ± 67 4552 ± 39 4638 ± 49 
Feed (% body weight day-1) 0.67 ± 0.01 0.72 ± 0.01 0.62 ± 0.06 
Gain (g) 2670 ± 33a 2280 ± 30b 2353 ± 50ab 
Gain (%) 123 ± 1a 100 ± 2b 103 ± 2b 
FCRb 1.34 ± 0.03 1.63 ± 0.05 1.37 ± 0.13 
SGRc 0.53 ± 0.0a 0.48 ± 0.01b 0.48 ± 0.01b 
Kd 1.77 ± 0.11 1.66 ± 0.12 1.72 ± 0.07 
DP (%)e 89.71 ± 0.35 89.46 ± 0.29 89.26 ± 0.95 
FY (%)f 60.05 ± 0.67 59.02 ± 0.7 60.68 ± 0.98 
HSI (%)g 1.05 ± 0.08 1.03 ± 0.04 0.96 ± 0.02 
VSI (%)h 10.00 ± 0.38 10.21 ± 0.26 9.68 ± 0.35 
Data are expressed as mean ± S.E.M., n = 3, N = 9. P < 0.05; one-way ANOVA with Tukey's post-
hoc test of multiple comparisons. 
a See Table 1 for experimental diet abbreviations. 
b FCR = food conversion ratio. 
c SGR = specific growth rate. 
d K = condition factor 
e DP (%) = dress-out percentage. 
f FY (%) = fillet yield percentage. 
g HSI (%) = hepatosomatic index. 
h VSI (%) = viscerosomatic index. 
 
 
 
  
Table 3 
Nutrient and fatty acids digestibility (apparent digestibility 
coefficient - ADC %) of the three experimental diets for Atlantic 
salmon. 
 Diets   
  FO20 CAM20 CAM40 
Nutrientsb       
DMb 61.4 ± 4.0 67.2 ± 1.1 67.0 ± 1.5 
Protein 74.1 ± 3.7 80.2 ± 0.7 78.2 ± 2.1 
Lipid 78.5 ± 4.0 81.0 ± 1.0 84.8 ± 1.4 
NFEb 75.8 ± 1.8a 71.0 ± 1.4a 63.6 ± 1.7b 
Energyc 71.4 ± 4.1 75.9 ± 1.1 76.3 ± 1.6 
        
Fatty acidsd       
Total FA (mg g-1 diet) 76.9 ± 4.5 80.4 ± 1.1 83.3 ± 1.7 
12:0 84.2 ± 3.4 85.3 ± 0.3 86.0 ± 1.4 
14:0 73.3 ± 4.0 71.9 ± 1.1 72.8 ± 1.4 
16:0 68.4 ± 4.1 69.2 ± 1.6 69.0 ± 1.1 
18:0 56.9 ± 4.3 57.7 ± 3.1 53.3 ± 1.1 
16:1n-7 88.7 ± 4.2 94.6 ± 0.3 94.2 ± 1.8 
18:1n-9 84.0 ± 5.1 91.1 ± 0.4 91.6 ± 2.3 
18:1n-7 82.9 ± 5.2 89.6 ± 0.4 90.0 ± 2.3 
20:1n-9 82.4 ± 5.6 93.3 ± 0.8 92.7 ± 2.4 
18:2n-6 85.5 ± 5.3 94.7 ± 0.5 94.5 ± 2.2 
20:2n-6 85.9 ± 3.9 93.0 ± 0.6 93.0 ± 2.3 
20:4n-6 86.6 ± 5.4 93.9 ± 0.6 90.6 ± 1.5 
18:3n-3 88.1 ± 4.6 96.6 ± 0.6 95.9 ± 2.0 
20:5n-3 90.5 ± 4.4 96.5 ± 0.3 95.2 ± 1.3 
22:5n-3 86.5 ± 5.6 93.5 ± 0.7 89.9 ± 2.2 
22:6n-3 87.8 ± 5.1 93.6 ± 0.7 92.3 ± 1.4 
Data are expressed as mean ± S.E.M., n = 3, N = 9. P < 0.05; one-
way ANOVA with Tukey's post-hoc test of multiple comparisons, 
different letters denote statistically significant difference.  
a See Table 1 for experimental diet abbreviations. 
b Nutrients: DM, dry matter; NFE, nitrogen-free extract. 
c Calculated on the basis of 23.6, 39.5 and 17.2 kJ g-1 of protein, fat 
and carbohydrate, respectively. 
d Total FA = total fatty acids 
e Value of 100 = fatty acid not detected in faeces. 
  
Table 4 
Proximate (mg g-1 of tissue) and fatty acid composition (µmol g-1 tissue) of fillets of 
Atlantic salmon fed the three experimental diets for 150 days. 
  Dietsa     
  FO20 CAM20 CAM40 
Proximate composition (mg g-1 of tissue)       
Moisture 661.2 ± 5.9 657.9 ± 5.8 649.7 ± 8 
Protein  212.8 ± 5.2 219.3 ± 2.1 219.4 ± 3.5 
Lipid  122.9 ± 4.2 110.2 ± 7.4 121.6 ± 6.8 
Ash 9.5 ± 0.4 9.5 ± 0.3 10.1 ± 0.4 
        
Fatty acids (µmol g-1 of tissue)       
Total FAb 351.6 ± 6.6 313.8 ± 17.9 341.9 ± 9.5 
SFAc 108.3 ± 3a 87.8 ± 5.3b 87.5 ± 2.1b 
14:0 11.3 ± 0.2a 7.5 ± 0.5b 7.5 ± 0.3b 
16:0 69.6 ± 1.9a 57.9 ± 3.4b 58.2 ± 1.4b 
18:0 22.7 ± 0.8a 19.0 ± 1.2ab 18.0 ± 0.4b 
Other SFAd 4.6 ± 0.2a 3.4 ± 0.2b 3.8 ± 0.2ab 
MUFA 185.6 ± 3 164.1 ± 10.2 175.7 ± 5.2 
16:1n-7 17.6 ± 0.4a 14.3 ± 0.9b 14.5 ± 0.7b 
18:1n-9 141.9 ± 2.1 129.3 ± 7.9 133.1 ± 3.6 
18:1n-7 10.5 ± 0.2a 8.4 ± 0.5b 8.7 ± 0.4b 
20:1n-9 8.8 ± 0.1ab 6.7 ± 0.5a 10.7 ± 0.7b 
Other MUFAe 6.8 ± 0.2ab 5.4 ± 0.3a 8.8 ± 1b 
Total trans FA 2.5 ± 0.1a 1.6 ± 0.2b 1.5 ± 0b 
PUFA 54.9 ± 0.5a 60.0 ± 2.2a 77.1 ± 2.4b 
18:2n-6 21.1 ± 0.2a 30.2 ± 1.3b 37.3 ± 1.2c 
20:2n-6 1.9 ± 0a 2.2 ± 0.2a 2.9 ± 0.1b 
20:4n-6 1.4 ± 0.1 1.4 ± 0 1.2 ± 0.1 
Other n-6 PUFAf 2.3 ± 0.1a 3.8 ± 0.2b 4.0 ± 0.3b 
n-6 PUFA 26.7 ± 0.3a 37.6 ± 1.6b 45.4 ± 1.4b 
n-6 LC PUFA 5.2 ± 0.1a 6.2 ± 0.3b 6.7 ± 0.2b 
18:3n-3 3.8 ± 0a 6.7 ± 0.4a 14.0 ± 1.3b 
20:5n-3 4.9 ± 0.1a 3.7 ± 0.1b 4.2 ± 0.4ab 
22:5n-3 2.2 ± 0.1a 1.5 ± 0.1b 1.7 ± 0.1b 
22:6n-3 12.6 ± 0.2a 7.9 ± 0.1b 8.3 ± 0.4b 
Other n-3 PUFAg 3.6 ± 0.1a 1.8 ± 0.1b 2.6 ± 0.1c 
n-3 PUFA 27.1 ± 0.3a 21.5 ± 0.5b 30.7 ± 1.5a 
n-3 LC PUFA 22.3 ± 0.3a 14.3 ± 0.1b 16.2 ± 0.6c 
LC PUFA 27.5 ± 0.4a 20.5 ± 0.4b 23.0 ± 0.8c 
n-6/n-3 ratio 1.0 ± 0.0a 1.7 ± 0.0b 1.5 ± 0.1c 
Data are expressed as mean ± S.E.M., n = 3, N = 9. P < 0.05; one-way ANOVA with Tukey's 
post-hoc test of multiple comparisons. 
a See Table 1 for experimental diet abbreviations.   
b Total FA = total fatty acids µmol g-1 of tissue. 
c See table 2 for fatty acid classes and abbreviations. 
d Other SFA = sum of 12:0, 15:0, 17:0, 20:0, 21:0, 22:0 & 24:0. 
e Other MUFA = sum of 14:1n-5, 15:1n-5, 17:1n-7, 20:1n-11, 22:1n-11 & 24:1n-9. 
f Other n-6 PUFA = sum of 18:3n-6, 20:3n-6, 22:2n-6, 22:4n-6, 22:5n-6. 
 Table 5 
Fillet fatty acid composition (as mg 100 g-1 of edible product and % of total fatty acids in 
brackets and italics) of Atlantic salmon fillet fed the three experimental diets for 150 days. 
  Dietsa     
mg 100 g-1 of fillet FO20 CAM20 CAM40 
20:5n-3 147.9 ± 3.8a (1.5) 110.6 ± 3.8b (1.2) 127.3 ± 11.0ab (1.4) 
22:5n-3 72.9 ± 2.6a (0.8) 48.4 ± 2.4b (0.6) 55.2 ± 2.7b (0.6) 
22:6n-3 414.8 ± 7.7a (4.2) 259.9 ± 3.7b (3.0) 272.0 ± 14.4b (2.9) 
SFAb 2814.6 ± 79.5a (28.8) 2291.3 ± 138.5b (26.3) 2282.4 ± 53.9b (23.9) 
MUFA 5227.8 ± 83.0 (53.5) 4627.7 ± 286.7 (53.0) 4977.6 ± 146.5 (52.1) 
PUFA 1644.7 ± 16.1a (16.9) 1756.6 ± 62.5a (20.2) 2242.1 ± 68.5b (23.5) 
LC-PUFA 879.7 ± 12.8a (9.0) 652.8 ± 11.7b (7.5) 729.0 ± 24.0c (7.6) 
trans 71.8 ± 2.1a (0.7) 45.6 ± 5.6b (0.5) 40.9 ± 0.6b (0.4) 
n-6 PUFA 743.0 ± 8.7a (7.6) 1056.3 ± 46.5b (12.1) 1276.6 ± 38.7c (13.4) 
n-6 LC PUFA 161.4 ± 2.6a (1.7) 194.2 ± 8.0b (2.2) 209.4 ± 7.4b (2.2) 
n-3 PUFA 850.4 ± 9.6a (8.7) 660.6 ± 15.0b (7.6) 924.0 ± 41.3a (9.7) 
n-3 LC PUFA 718.3 ± 10.8a (7.4) 458.6 ± 3.9b (5.3) 519.6 ± 18.2c (5.4) 
n-6/n-3 ratio 0.9 ± 0.0a 1.6 ± 0.0b 1.4 ± 0.1c 
Data are expressed as mean ± S.E.M., n = 3, N = 9. P < 0.05; one-way ANOVA with Tukey's 
post-hoc test of multiple comparisons. 
a See Table 1 for experimental diet abbreviations. 
b See table 2 for fatty acid classes and abbreviations. 
 
 
  
  
g Other n-3 PUFA = sum of 18:4n-3, 20:4n-3, 22:3n-3, 24:5n3 & 24:6n-3. 
  
Table 6 
The apparent in vivo fatty acid β-oxidation (nmol g-1 day-1 and % of total intake in brackets and 
italics) in Atlantic salmon fed the three experimental diets for 150 days. 
  Dietsa     
  FO20 CAM20 CAM40 
12:0 5.2 ± 0.2a (64.5)  6.2 ± 0.2a (74.7)  3.7 ± 0.5b (69.5)  
14:0 104.5 ± 5.7a (40.3)  92.3 ± 2.2a (46.8)  55.6 ± 9.7b (39.3)  
16:0 661.3 ± 29.8a (37.2)  725.7 ± 14.8a (41.4)  380.3 ± 76.1b (30.6)  
18:0 289.3 ± 9.6a (35.2)  434.2 ± 4.0b (41.0)  133.4 ± 27.7c (21.4)  
22:0 8.7 ± 0.3a (25.6)  16.8 ± 0.2b (87.0)  22.9 ± 1.5c (90.5)  
SFAb,c   1068.9 ± 45.3a 1275.3 ± 19.7a  596.0 ± 115.3b 
14:1n-5 31.6 ± 1.5a (58.7)  14.7 ± 0.8b (59.4)  23.3 ± 3.2a (64.4)  
16:1n-7 135.7 ± 8.7a (43.3)  87.5 ± 4.9b (39.1)  50.1 ± 17.3a (27.8)  
18:1n-7 31.4 ± 4.1 (22.9)  47.8 ± 3.8 (40.9)  28.5 ± 9.3 (29.8)  
18:1n-9 765.8 ± 60.1ab (33.5)  1190.7 ± 41.3a (49.8)  744.6 ± 181.1b (38.4)  
20:1n-9 6.9 ± 2.6a (6.2)  21.7 ± 1.6a (24.9)  98.1 ± 20.9b (41.3)  
22:1n-9 11.8 ± 0.9ab (40.7)  1.3 ± 0.7a (8.3)  19.1 ± 4.5b (35.7)  
24:1n-9 7.3 ± 0.3a (57.8)  1.7 ± 0.4b (37.2)  4.5 ± 0.8c (45.6)  
20:1n-11 16.5 ± 0.9 (56.7)  ─d ─ 
22:1n-11 51.7 ± 0.7a (100)  13.1 ± 0.0b (100)  14.2 ± 0.5b (100)  
MUFA 1058.6 ± 79.7 1378.4 ± 52.5 982.3 ± 237.0 
18:2n-6 100 ± 10.9a (39.6)  250.9 ± 17.4b (50.8)  219.7 ± 56.3ab (38.9)  
20:2n-6 0.4 ± 0.3 (3.3)  3.1 ± 0.7 (18.1)  6.0 ± 3.2 (18.4)  
22:2n-6 4.7 ± 0.2a (76.9)  8.1 ± 0.6b (83.2)  3.9 ± 0.8a (60.8)  
18:3n-6 0.4 ± 0.1 (16.3)  ─ ─ 
20:3n-6 11.1 ± 0.7a (77.2)  1.5 ± 0.3b (10.5)  4.4 ± 1.2b (24.6)  
20:4n-6 9.3 ± 0.6a (52.8)  2.8 ± 1.3b (22.4)  0.2 ± 0.1b (3.2)  
22:4n-6 1.1 ± 0.1a (41.3)  0.7 ± 0.1b (44.1)  ─ 
22:5n-6 8.5 ± 0.3a (73.4)  4.9 ± 0.1b (94.7)  3.0 ± 0.3c (97.3)  
n-6 PUFA 135.5 ± 12.9 272.2 ± 18.8 237.3 ± 61.7 
18:3n-3 1.2 ± 1.2a (2.1)  153.8 ± 3.8b (72.6)  348.4 ± 56.1c (63.2)  
22:3n-3 11.8 ± 0.2a (100)  5.9 ± 0b (100)  6.8 ± 0.5b (94.3)  
20:5n-3 64.5 ± 3.2a (66.4)  13.5 ± 3.1b (53.0)  1.4 ± 1.4c (5.6)  
22:5n-3 6.8 ± 0.1a (30.5)  3.3 ± 0.6b (46.1)  ─ 
24:5n-3 ─ 0.6 ± 0.3 (100)  0.3 ± 0.3 (100)  
24:6n-3 ─ ─ 0.1 ± 0.1 (100)  
22:6n-3 33.8 ± 3.9a (25.5)  7.1 ± 4.2b (19.4)  3.7 ± 3.5b (10.5)  
n-3 PUFA 118.1 ± 6.9a 184.3 ± 9.1a 360.7 ± 60.5b 
Total FA 2381.1 ± 144.1 3110.2 ± 99.9 2176.2 ± 473.6 
Data are expressed as mean ± S.E.M., winter phase; n = 3, N = 9. P < 0.05; one-way ANOVA with 
Tukey's post-hoc test of multiple comparisons, different letters denote statistically significant 
difference.  
a See Table 1 for experimental diet abbreviations. 
b See table 2 for fatty acid classes and abbreviations. 
c Fatty acids not recording any β-oxidation are not reported in this table. 
d β-oxidation not detected. 
Table 7 
The apparent in vivo fatty acid bioconversion (elongation, desaturation or chain 
shortening) (nmol g-1 day-1) in Atlantic salmon fed the three experimental diets for 
150 days. 
  Dietsa 
    
  FO20 CAM20 CAM40 
Fatty acid elongationb       
18:0 to 20:0 1.6 ± 0.0a (0.2) 12.0 ± 2.2b (1.1) 44.0 ± 3.2c (7.3) 
22:0 to 24:0 4.0 ± 0.2a (57.5) 0.1 ± 0.1b (0.5) ─ 
18:2n-6 to 20:2n-6 0.4 ± 0.4 (0.2) ─ 0.1 ± 0.1 (2.4) 
20:4n-6 to 22:4n-6 ─c ─ 0.1 ± 0.1 (1.6) 
18:3n-3 to 20:3n-3 2.0 ± 0.2a 2.6 ± 0.5ab 5.7 ± 1.2b 
18:4n-3 to 20:4n-3 18.6 ± 0.2a 1.7 ± 0.2b 5.2 ± 2.2b 
20:5n-3 to 22:5n-3 ─ ─ 3.7 ± 2.5 
22:5n-3 to 24:5n-3 1.3 ± 0.4 0.1 ± 0.1 2.4 ± 2.4 
Fatty acid ∆-5 desaturation       
20:4n-3 to 20:5n-3 ─ ─ 3.6 ± 2.0 
Fatty acid ∆-6 desaturation       
18:2n-6 to 18:3n-6 ─ 10.6 ± 1.2 13.2 ± 1.5 
18:3n-3 to 18:4n-3 31.1 ± 0.7a (60.8) 8.2 ± 0.3b (5.1) 12.3 ± 2.4b (3.5) 
24:5n-3 to 24:6n-3 1.1 ± 0.2 ─ 2.2 ± 2.1 
Fatty acid ∆-9 desaturation       
20:0 to 20:1n-11 ─ 10.2 ± 1.9a 37.1 ± 3.0b 
Fatty acid chain shortening       
24:6n-3 to 22:6n-3 ─ ─ 2.0 ± 2.0 
Data are expressed as mean ± S.E.M., n = 3, N = 9. P < 0.05; one-way ANOVA with 
Tukey's post-hoc test of multiple comparisons, different letters denote statistically 
significant difference. 
a See Table 1 for experimental diet abbreviations. 
b Fatty acids not recording any bioconversion (elongation or desaturation) are not 
reported in this table. 
c Not detected 
  
Table 8 
Consumer preference of salmon products (raw salmon, cold smoked and hot smoked 
fillet) and major influential attributes (fishiness, saltiness and oiliness) from the three 
dietary treatments. 
  Dietsa     
  FO20 CAM20 CAM40 
Preference; Like ( + ) or Dislike ( - )b     
Raw 6.21 ± 0.4 1.77 ± 1.94 2.68 ± 0.19 
Cold smoked 13.16 ± 1.87 11.71 ± 3.19 17.52 ± 4.68 
Hot smoked 19.15 ± 4.02 19.61 ± 1.55 18.95 ± 2.66 
Influential attributesc       
Fishinessc       
Raw 0.5 ± 0.97 1.13 ± 0.74 -1.21 ± 3.48 
Cold smoked 3.82 ± 0.85 3.94 ± 1.06 2.52 ± 0.69 
Hot smoked 0.15 ± 2.33 -1.69 ± 0.39 -0.48 ± 2.76 
Saltinessc       
Raw -21.32 ± 0.39 -20.12 ± 1.54 -20.08 ± 3.06 
Cold smoked 6.31 ± 0.95a 11.04 ± 0.8b 7.17 ± 0.36ab 
Hot smoked 5.66 ± 0.53 6.84 ± 0.55 6.39 ± 3.45 
Oilinessc       
Raw -2.63 ± 2.18 -4.02 ± 0.71 -4.2 ± 0.62 
Cold smoked 6.02 ± 0.69 3.03 ± 4.23 5.27 ± 2.3 
Hot smoked -2.74 ± 0.47 -3.75 ± 1.4 -4.27 ± 1.89 
Data are expressed as mean ± S.E.M., n = 3, N = 9. P < 0.05; one-way ANOVA with 
Tukey's post-hoc test of multiple comparisons. 
a See Table 1 for experimental diet abbreviations. 
b Salmon preferences were assessed using hedonic LMS scales. 
c Attributes consumers determined had greatest influence over preference 
 
  
 Figure 1. 
